Stock listing
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A
Selected listing: 603707 · SSE · CNY · CN
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A (Shanghai:603707), Health Technology. News releases, investor calls and events on 6ix.

- Ticker
- Shanghai:603707
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Shanghai
- Currency
- CNY
About Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A, traded under the ticker 603707, operates in the Chinese market. It specializes in biochemical and pharmaceutical products, contributing to the healthcare sector in China.
Latest news from Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A
"Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd."Announcement on Obtaining U.S. FDA Approval for Adalimumab Injection of Subsidiary
September 29, 2026
"Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd."Announcement on Obtaining U.S. FDA Approval for Vitamin B1 Injection of Subsidiary
September 28, 2026
"Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd."Announcement on Participation in Subscription of Private Fund Units by Wholly-owned Subsidiary
September 24, 2026
"Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd."Announcement on Subsidiary's Receipt of U.S. FDA Approval for an Additional Manufacturing Site for Amikacin Sulfate Injection
September 22, 2026
"Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd."Announcement on Subsidiary's Receipt of U.S. FDA Approval for an Additional Manufacturing Site for Adalimumab Injection
September 1, 2026
All Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A news →
Research Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A company profile
View the public company page for Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A on 6ix.
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A news
Read company news and market updates connected to Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A.
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A investor events
Find investor webinars, events, and replay context for Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A.